-+ 0.00%
-+ 0.00%
-+ 0.00%

ARDELYX: TOPLINE DATA FROM PHASE 3 ACCEL TRIAL EXPECTED IN H2 2027

Reuters·11/03/2026 13:00:02

Please log in to view news